Verona Pharma (VRNA) PT Raised to $35 at Canaccord Genuity
Tweet
Share
E-mailGet Alerts VRNA Hot Sheet
Price: $106.91 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Canaccord Genuity analyst Edward Nash raised the price target on Verona Pharma (NASDAQ: VRNA) to $35.00 (from $33.00) while maintaining a Buy rating.
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- JPMorgan Upgrades KCE Electronics PCL (KCE:TB) to Overweight
- Kikkoman (2801:JP) PT Raised to JPY2,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
